Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-31

Clinical Trial Update: Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19 [NA]

View source ↗

Summary

A planned clinical trial from the University of Calgary will evaluate whether creatine supplementation can reduce fatigue in people with Long COVID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creatine monohydrate (creatine monohydrate)

Snippet

Sponsor: University of Calgary | Conditions: Long COVID Fatigue | NA | Status: NOT_YET_RECRUITING